Antibody against amino acid sequence RGD of extracellular matrix protein and its production and use

摘要

The present invention provides monoclonal antibodies that specifically recognize the amino acid sequence RGD of human and mouse extracellular matrix proteins. By specifically inhibiting adhesion via the RGD sequence, it is possible to expect an effective effect on diseases such as inflammation, cancer, infectious diseases, autoimmunity, osteoporosis, and reduction of side effects. Treatment can be provided.